Biobank For MS And Other Demyelinating Diseases

Sponsor
Accelerated Cure Project for Multiple Sclerosis (Other)
Overall Status
Active, not recruiting
CT.gov ID
NCT00445367
Collaborator
(none)
3,226
10
365
322.6
0.9

Study Details

Study Description

Brief Summary

To establish a large, longitudinal collection of high quality samples and data from subjects with MS, selected other demyelinating diseases (Transverse Myelitis (TM), Neuromyelitis Optica (NMO) or Devic's, Acute Disseminated Encephalomyelitis (ADEM), and Optic Neuritis (ON)), and related and unrelated unaffected controls. Samples and data will be available as a shared resource to scientists researching the causes, sub-types, and biomarkers of MS and related demyelinating diseases.

Study Design

Study Type:
Observational
Actual Enrollment :
3226 participants
Observational Model:
Case-Control
Time Perspective:
Other
Official Title:
Large-scale, Multi-disciplinary Sample and Data Repository for Multiple Sclerosis and Related Demyelinating Diseases
Study Start Date :
May 1, 2006
Anticipated Primary Completion Date :
Oct 1, 2026
Anticipated Study Completion Date :
Oct 1, 2036

Arms and Interventions

Arm Intervention/Treatment
Case

Control

Outcome Measures

Primary Outcome Measures

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    N/A and Older
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    Yes
    Inclusion Criteria:
    • age 18+ able to give informed consent or individuals younger than 18 with parental permission and able to give assent

    • willing to provide up to 110 ml (50 ml for < 18 years old) of blood via venipuncture

    • experienced at least one CNS demyelinating event characteristic of MS, TM, NMO, ADEM, or ON

    Exclusion Criteria:
    • history of blood borne pathogens

    • allogeneic bone marrow transplant

    • clinical or radiological evidence of stroke, meningitis, or other well characterized diseases of the nervous system (with the exception of MS, TM, NMO, ADEM, or ON).

    • weight less than 37 pounds

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Barrow Neurological Institute Phoenix Arizona United States 85013
    2 Stanford University Stanford California United States 94305
    3 The Rocky Mountain MS Center at Anschutz Medical Campus at UC Denver Aurora Colorado United States 80045
    4 Shepherd Center Atlanta Georgia United States 30309
    5 Johns Hopkins Baltimore Maryland United States 21287
    6 Beth Israel Deaconess Boston Massachusetts United States 02215
    7 University of Massachusetts Medical School Worcester Massachusetts United States 01605
    8 Multiple Sclerosis Research Center of New York New York New York United States 10019
    9 The Ohio State University Columbus Ohio United States 43210
    10 University of Texas Southwestern Medical Center at Dallas Dallas Texas United States 76051

    Sponsors and Collaborators

    • Accelerated Cure Project for Multiple Sclerosis

    Investigators

    • Principal Investigator: Benjamin Greenberg, M.D., M.H.S., University of Texas

    Study Documents (Full-Text)

    None provided.

    More Information

    Additional Information:

    Publications

    None provided.
    Responsible Party:
    Accelerated Cure Project for Multiple Sclerosis
    ClinicalTrials.gov Identifier:
    NCT00445367
    Other Study ID Numbers:
    • ACP-001
    First Posted:
    Mar 9, 2007
    Last Update Posted:
    Jul 20, 2021
    Last Verified:
    Jul 1, 2021

    Study Results

    No Results Posted as of Jul 20, 2021